on INVENTIVA (EPA:IVA)
Inventiva Combined General Meeting: Documents Available
Inventiva, a biopharmaceutical company specializing in the development of treatments for non-alcoholic steatohepatitis (NASH), announces the terms of access to the preparatory documents of its Combined General Meeting scheduled for December 11, 2024. Shareholders are invited to the event in Dijon, France.
The agenda includes resolutions for a €348 million financing through the issuance of shares. Shareholders will also vote on the appointment of new directors and on executive remuneration policies.
The documents are available on Inventiva's website. Shareholders can consult them at the registered office or request direct delivery. The company provides information for an informed vote.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INVENTIVA news